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Background. Heat shock protein 70 (Hsp70) has been shown to exert cardioprotection. Intracellular calcium ([Ca2+]i) overload
induced by p38 mitogen-activated protein kinase (p38 MAPK) activation contributes to cardiac ischemia/reperfusion (I/R)
injury. However, whether Hsp70 interacts with p38 MAPK signaling is unclear. Therefore, this study investigated the regulation
of p38 MAPK by Hsp70 in I/R-induced cardiac injury. Methods. Neonatal rat cardiomyocytes were subjected to oxygen-glucose
deprivation for 6 h followed by 2 h reoxygenation (OGD/R), and rats underwent left anterior artery ligation for 30min followed
by 30min of reperfusion. The p38 MAPK inhibitor (SB203580), Hsp70 inhibitor (Quercetin), and Hsp70 short hairpin RNA
(shRNA) were used prior to OGD/R or I/R. Cell viability, lactate dehydrogenase (LDH) release, serum cardiac troponin I (cTnI),
[Ca2+]i levels, cell apoptosis, myocardial infarct size, mRNA level of IL-1β and IL-6, and protein expression of Hsp70,
phosphorylated p38 MAPK (p-p38 MAPK), sarcoplasmic/endoplasmic reticulum Ca2+-ATPase2 (SERCA2), phosphorylated
signal transducer and activator of transcription3 (p-STAT3), and cleaved caspase3 were assessed. Results. Pretreatment with a
p38 MAPK inhibitor, SB203580, significantly attenuated OGD/R-induced cell injury or I/R-induced myocardial injury, as
evidenced by improved cell viability and lower LDH release, resulted in lower serum cTnI and myocardial infarct size,
alleviation of [Ca2+]i overload and cell apoptosis, inhibition of IL-1β and IL-6, and modulation of protein expressions of p-p38
MAPK, SERCA2, p-STAT3, and cleaved-caspase3. Knockdown of Hsp70 by shRNA exacerbated OGD/R-induced cell injury,
which was effectively abolished by SB203580. Moreover, inhibition of Hsp70 by quercetin enhanced I/R-induced myocardial
injury, while SB203580 pretreatment reversed the harmful effects caused by quercetin. Conclusions. Inhibition of Hsp70
aggravates [Ca2+]i overload, inflammation, and apoptosis through regulating p38 MAPK signaling during cardiac I/R injury,
which may help provide novel insight into cardioprotective strategies.
1. Introduction
Myocardial ischemia/reperfusion (I/R) injury is a common
and complicated pathophysiological phenomenon that
leads to arrhythmias, myocardial stunning, and heart fail-
ure [1]. Recent studies have investigated cardioprotective
therapies in the animal models of I/R-induced myocardial
injury [2–4]. Despite recent progress, preventing and treat-
ing myocardial I/R injury remains an unsolved problem in
the clinical settings.
Several possible underlying mechanisms include intra-
cellular calcium([Ca2+]i)overload,oxidative stress, inflamma-
tory reactions, apoptosis, autophagy, and platelet aggregation
and embolization [5–7]. Of these, [Ca2+]i overload is a major
etiological factor associated with Ca2+ homeostasis disorders,
apoptosis, and other types of cell damage during cardiac I/R
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injury [6, 8–11]. In the heart, p38 mitogen-activated pro-
tein kinase (p38 MAPK) is involved in the regulation of
cardiac contractile function. Previous studies showed that
inhibition of p38 MAPK protected against myocardial
I/R injury [12, 13]. Moreover, Kaikkonen et al. found that
inhibition of p38 MAPK enhanced diastolic Ca2+ uptake
and improved cardiomyocyte contractile function [14].
However, the upstream mechanism of p38 MAPK regulat-
ing [Ca2+]i during myocardial I/R injury needs further
investigations.
The 70 kDa heat shock protein (Hsp70), a member of the
HSP family, is a highly conserved protein widely expressed in
all living organisms. Hsp70 plays an important role in pro-
tecting cellular homeostasis from stress via its molecular
chaperone functions [15]. Peng et al. showed that Hsp70
was involved in cell survival signaling during oxidative stress
and I/R injury of rat cardiomyocytes [16]. Other studies
found that the Hsp70 expression was upregulated in I/R-
induced myocardial injury, which may help to alleviate cell
apoptosis [17, 18]. In skeletal muscle regeneration, Hsp70
regulated p38 MAPK stability by interaction with MAPK-
activated protein kinase 2 [19]. In the context of myocardial
I/R injury, however, whether Hsp70 affects p38 MAPK sig-
naling is unclear.
In this study, we investigated the protective role of Hsp70
and its regulation of p38 MAPK signaling during I/R-
induced cardiac injury, in vivo and in vitro. We hypothesized
that inhibition of Hsp70 could aggravate [Ca2+]i overload
and cell apoptosis, and these effects are medicated through
the p38 MAPK signaling pathway. The results of this study
may help to identify potential targets for the prevention
and therapeutics of myocardial I/R injury.
2. Materials and Methods
2.1. Animals. Adult male Sprague-Dawley (SD) rats
(270 ± 20 g) and neonatal rats (aged 24–48h) were provided
by the Experimental Animal Center of Soochow University
(license No. SYXK Jiangsu 2017-0043) and were kept under
a controlled condition (temperature of 24–26°C, relative
humidity 40–60%, 12 h light–dark cycle; free access to food
and water). The study protocol was approved by the Institu-
tional Animal Care and Use Committee of Soochow Univer-
sity (Suzhou, Jiangsu, China). All experimental procedures
were performed in accordance with the Guide for the Care
of Use of Laboratory Animals (NIH publication No. 85-23,
revised in 1996).
2.2. Isolation and Culture of Neonatal Rat Cardiomyocytes.
The primary cultured cardiomyocytes were obtained as pre-
viously described [20]. Briefly, neonatal rats were anesthe-
tized with isoflurane and euthanized by cervical dislocation.
The hearts were rapidly harvested in ice-cold phosphate-
buffered saline (PBS). The ventricular myocardium was
minced into 1mm3 pieces, followed by digestion with 0.1%
collagenase type II (Sigma, St. Louis, MO, USA) at 37°C for
5min. After digestion for 5 times, Dulbecco’s modified
Eagle’s medium (DMEM, HyClone, USA) containing 10%
fetal bovine serum (FBS, Biological Industries, Israel) was
added. The cell suspension was centrifuged at 500 g at 4°C
for 10min and resuspended in medium containing 10%
FBS. After incubation at 37°C for 120min, fibroblasts were
removed and nonadherent cells were collected. To inhibit
fibroblast growth, 0.1mM 5-bromodeoxyuridine (5-BrdU,
Sigma, St. Louis, MO, USA) was added. Cardiomyocytes
were incubated at 37°C in 95% air and 5% CO2 for subse-
quent experiments.
2.3. Oxygen-Glucose Deprivation/Reoxygenation (OGD/R).
To induce OGD/R, the cardiomyocytes were treated with
glucose-free DMEM (Gibco, Carlsbad, CA, USA) and incu-
bated at 37°C in a hypoxia chamber containing 95% N2 and
5% CO2, as previous described [21]. Cells were subjected to
OGD for 6 h, followed by reoxygenation in normal DMEM
medium for 2, 12, or 24h, respectively.
2.4. Myocardial I/R. Rats were anesthetized with 50mg/kg
sodium pentobarbital intraperitoneally. Then, the rats were
intubated and the lungs were ventilated with oxygen-
enriched room air (21% O2, tidal volume = 20ml/kg, ratio =
1 : 1, and frequency = 70 breaths/min) on a small animal
ventilator (R407, RWD, China). After a left thoracotomy,
the left anterior artery was ligated by using a 5-0 Prolene
suture to induce left ventricular myocardial ischemia for
30min. Subsequently, the ligature was removed to restore
the blood flow for 30min, 2 h, or 24h, respectively. The
sham rats underwent the same surgical procedure without
ligation. Throughout the surgery, rat body temperature
was maintained at 37°C by using a heating pad (Physitemp
Instruments, USA). Local infiltration with 1% lidocaine
3ml was used for postoperative analgesia.
2.5. Experimental Protocol. The protocol of this study is
shown in Figure 1, including in vitro and in vivo experiments
in three parts. A computer-generated randomization table
was used to assign the cells or rats into different groups.
The following parameters were assessed: cell viability, lactate
dehydrogenase (LDH) release, myocardial infarct size, serum
cardiac troponin I (cTnI), level of [Ca2+]i, mRNA level of
interleukin 1β (IL-1β) and interleukin-6 (IL-6), apoptosis
rate, and protein expression of Hsp70, p-p38 MAPK, p38
MAPK, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
(SERCA2), signal transducer and activator of transcrip-
tion3 (STAT3), p-STAT3, cleaved caspase3, and caspase3.
In each part, separate experiments were performed for
the sham and I/R groups in rats and control and OGD/R
groups in cells.
Part 1: Neonatal rat cardiomyocytes were randomly
divided into a control group and four OGD/R groups.
The control group received normal culture. In the OGD/R
groups, cells underwent OGD for 6 h followed by reoxy-
genation for 0, 2, 12, and 24 h, respectively. Rats were
randomly divided into a sham group and three I/R
groups. In the I/R groups, rats were subjected to myocardial
ischemia for 30min followed by reperfusion for 30min, 2 h,
or 24h, respectively.
Part 2: To investigate the role of p38MAPK in cardiac I/R
injury, the effects of SB203580, a p38 MAPK inhibitor, on
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OGD/R-induced cell injury and I/R-induced myocardial
injury were evaluated [22–24]. Cells were randomly divided
into three groups: control group, OGD/R group, and SB
203580 + OGD/R group (incubation with 10μM SB203580
1h prior to OGD). Rats were randomly divided into three
groups: sham group, I/R group, and SB203580 + I/R group
(intraperitoneal injection of 2mg/kg SB203580 1h prior to
myocardial ischemia).
Part 3: To explore the role of Hsp70 and its relationship
with p38 MAPK in cardiac I/R injury, the effects of Hsp70
knockdown or inhibition, in combination with SB203580,
on OGD/R-induced cell injury or I/R-induced myocardial
injury were evaluated.
or Hsp70 knockdown in cells, the sequence of short hair-
pin RNA (shRNA, Genechem, Shanghai, China) targeting
Hsp70 (NM_031971) was 5′GCCCAAGGTGCAGGTG
AACTA-3′. Cells were randomly divided into four groups:
negative control group (negative control transfection for
48 h followed by culture in normal conditions), NC +
OGD/R group (negative control transfection for 48 h prior
to OGD/R), sh −Hsp70 + OGD/R group (Hsp70-shRNA
transfection for 48 h prior to OGD/R), and sh −Hsp70 +
SB + OGD/R group (Hsp70 shRNA transfection for 48 h
prior to 10μM SB2203580 treatment, followed by OGD/R).
Transfection was performed by using the jetOPTIMUS®
transfection regent (Polyplus-transfection®SA, Strasbourg,
Bas-Rhin, France).
For Hsp70 inhibition in rats, 20mg/kg quercetin
(Apexbio, Houston, TX, USA) was intraperitoneally injected
[25, 26]. Rats were randomly divided into four groups:
sham group (sham operation with normal saline injection),
I/R group (myocardial I/R with saline injection), Quercetin
sh-Hsp70+SB+OGD/R
NC+OGD/R OGD Reoxygenation
1 h
NC
6 h 2 h48 h
Negative control
6 h 2 h48 h
Negative control
OGD
6 h 2 h48 h
OGD
6 h 2 h48 h
I/R
Que+SB+I/R
Que+I/R
Sham
30 min 30 min
Ischemia Reperfusion
Quercetin (20 mg/kg)
1 h
SB203580 (2 mg/kg)
30 min 30 min
Ischemia
Quercetin (20 mg/kg)
1 h 30 min 30 min
Ischemia Reperfusion
30 min 30 min
1 h
1 h
Vehicle
Vehicle
Reoxygenation
Reoxygenation
Reperfusion
Part III
OGD/R OGD Reoxygenation
Control
2 h~24 h6 h
I/R
Sham
Ischemia Reperfusion
30 min~24 h30 min
Part I
2 h~24 h6 h 30 min~24 h30 min
OGD/R OGD Reoxygenation
Control
2 h6 h
I/R
Sham
Reperfusion
30 min30 min
Part II
1 h 1 h
Ischemia
30 min30 min1 h
SB203580 (2 mg/kg)
1 h 30 min 30 min
Ischemia ReperfusionSB+I/R
1 h 2 h6 h
1 h 2 h6 h
SB+OGD/R OGD Reoxygenation
SB203580 (10 𝜇M)
SB203580 (10 𝜇M)
Hsp70 transfectionsh-Hsp70+OGD/R
sh-Hsp70 transfection
Figure 1: Study protocol. Part I: neonatal rat cardiomyocytes were subjected to OGD/R, and rats underwent myocardial I/R. Part II: the p38
MAPK inhibitor (SB203580) was used 1 h prior to OGD in cells or before myocardial ischemia in rats. Part III: cells were transfected with
Hsp70 shRNA for 48 h and treated with SB203580 1 h prior to OGD, and rats received Quercetin (an Hsp70 inhibitor) and SB203580 1 h
prior to myocardial ischemia. OGD/R: oxygen-glucose deprivation/reoxygenation; I/R: ischemia/reperfusion.
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+ I/R group (Quercetin injection 1 h prior to myocardial
I/R), and Quercetin + SB203580 + I/R group (Quercetin and
SB203580 injection 1h prior to myocardial I/R).
2.6. Cell Viability. Cell viability was assessed by using the Cell
Counting Kit (CCK)-8 (Dojindo Laboratories, Kumamoto,
Japan) according to the manufacturer’s instructions. Briefly,
cells were cultured in 96-well plates. At the end of reoxygen-
ation, 10μL CCK8 solution was added to each well, followed
by 1h of incubation at 37°C. The absorbance values were
measured at 450nm by using a microplate reader (Molecular
Devices, Sunnyvale, CA, USA).
2.7. LDH Release. At the end of reoxygenation, LDH release
were detected by using the LDH Assay kit (ab65393, Abcam,
Cambridge, UK). The cell culture plates were centrifuged at
600 g for 10min, and supernatants (10μl/well) were
extracted into another 96-well plate. Then, 100μl LDH reac-
tion mix was added to each well and incubated at room tem-
perature for 30min. The absorbance values were measured at
490nm on the microplate reader.
2.8. Blood Analysis. At the end of reperfusion, 0.5ml blood
sample was taken from the abdominal aorta and analyzed
by using a blood gas analyzer (Radiometer, ABL80 FLEX,
Carlsbad, CA, USA). The values of pH, partial pressure of
arterial oxygen (PO2), partial pressure of arterial carbon
dioxide (PaCO2), hematocrit (Hct), hemoglobin [6], sodium
(Na+), and potassium (K+) were measured.
2.9. Myocardial Infarct Size. Myocardial infarct size was
determined by using the Evans blue/2,3,5-triphenyl tetrazo-
lium chloride (TTC) staining, as previously described [27].
At the end of reperfusion, the LAD was reoccluded and
3ml Evans blue dye (2% w/v, E2129, Sigma-Aldrich Corp.,
St. Louis, MO, USA) was injected via the inferior vena cava
to identify the area at risk (AAR, area not stained by Evans
blue). The heart was rapidly removed and frozen at -20°C
for 30min. After atrium removal, the left ventricle was sec-
tioned into slices of 2mm thick. The slices were immedi-
ately incubated with phosphate-buffered 1% TTC (T8877,
Sigma-Aldrich Corp., St. Louis, MO, USA) at 37°C for
30min, fixed in 10% formalin solution overnight, and then
photographed. The infarct size was calculated as the ratio
of infarct area (IA, area not stained by TTC) to AAR.
The images were analyzed by using the Image J software
(version 1.48, National Institutes of Health, Bethesda,
MD, USA).
2.10. Western Blotting. Total protein was extracted by using
the RIPA reagents (P0013B, Beyotime, Shanghai, China),
and the protein concentration was determined with a
bicinchoninic acid reagent kit (P1002, Beyotime, Shanghai,
China) [2]. Proteins were then separated by sodium dodecyl
sulphate-polyacrylamide gel electrophoresis on 10% gels and
transferred to polyvinylidene fluoride membranes (Millipore
Corp., Bedford, MA) at 200mA for 80min at 4°C. After
blocking with 5% milk for 2 h at room temperature, the
bands were incubated overnight at 4°C with the following
specific primary antibodies: Hsp70 (1 : 1000, ab2787, Abcam,
Cambridge, MA, USA), p38 MAPK (1 : 1000, ab32142,
Abcam, Cambridge, MA, USA), p-p38 MAPK (1 : 1000,
4511, Cell Signaling Technology, Beverly, MA, USA), SER-
CA2a (1 : 500, ab2861, Abcam, Cambridge, MA, USA),
STAT3 (1 : 1000, ab68153, Abcam, Cambridge, MA, USA),
pSTAT3 (1 : 1000, 9145, Cell Signaling Technology, Beverly,
MA, USA), and β-tubulin (1 : 1000, 2148, Cell Signaling
Technology, Beverly, MA, USA). The membranes were then
incubated with horseradish peroxidase-conjugated second-
ary antibodies (1 : 5000, Santa Cruz Biotechnology, CA,
USA) for 2 h at room temperature. Finally, the bands were
visualized by using the ChemiDocTM XRS+ System (Bio-
Rad, Richmond, CA) with an enhanced chemiluminescence
kit (Beyotime, Shanghai, China). The densities of protein
bands were normalized to β-tubulin as control.
2.11. Quantitative Real-Time Polymerase Chain Reaction.
Total RNA was extracted by using the TRIZOL reagent (Invi-
trogen; Thermo Fisher Scientific, Inc. Waltham, MA, USA),
as previously described [20]. RNA quantification and purity
control were determined by absorbance at 260 and 280 nm.
Reverse transcription was performed by using a cDNA Syn-
thesis Kit (Applied Biological Materials, Richmond, BC, Can-
ada). RNA samples were added to 5× All-in-one and DEPC
water in a 20μl reaction system for reverse transcription to
cDNA. Quantitative real-time polymerase chain reaction
(PCR) was conducted with EvaGreen qPCR MasterMix
(Applied Biological Materials, Richmond, BC, Canada) in a
10μl reaction volume on the Roche Light Cycler R480 Sys-
tem (Roche, Bedford, MA, USA). The amplification condi-
tions were predenaturation at 95°C for 10 s, denaturation at
58°C for 15 s, and annealing at 75°C for 20 s for 40 cycles.
The expression of target gene was analyzed by using the
2−ΔΔCT method and normalized to β-tubulin. Three repli-
cates were tested for each sample. The primers were provided
by Shanghai Shenggong Co., Ltd., and the sequences were:
IL-1β, 5’-ATCTCACAGCAGCATCTCGACAAG-3’(for-
ward), and 5’-CACACTAGCAGGTCGTCATCATCC-
3’(reverse); IL-6, 5’-AGGAGTGGCTAAGGACCAAGACC-
3’(forward), and 5’-TGCCAGGTAGACCTCATAGTGAC
C-3’(reverse); and β-tubulin, 5’-GGGAGGTGATAAGCGA
TGAA-3’(forward), and 5’-AGGGACATACTTGCCACC
TG-3’(reverse).
2.12. TUNEL Assay. At the end of reperfusion or reoxygena-
tion, the cardiac tissues or cardiomyocytes were fixed in 4%
formaldehyde at room temperature for 24h, embedded in
paraffin, and cut into 4μm slices. Myocardial apoptosis was
assessed by terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL) assay with the in situ Cell
Death Detection kit (Roche Diagnostics, Basel, Switzerland),
as previously described [28]. The nuclei were dyed with 4′,6-
Diamidino-2-Phenylindole (DAPI, Beyotime, Shanghai,
China). Samples were photographed under a fluorescence
microscope (Nikon, Tokyo, Japan). Cell nuclei were counted
in four random and nonoverlapping fields. The ratio of
TUNEL-positive cells to total number of cells was calculated
as the apoptosis index.
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2.13. Intracellular Calcium Assay. The level of [Ca2+]i in car-
diomyocytes was measured by using the flow cytometry
method [29]. Briefly, cells were collected and washed with
Hank’s balanced salt solution (HBSS) three times. Then, cells
were incubated with 5μM Fluo-3/AM (Sigma, St. Louis, MO,
USA) solution at 37°C for 30min. After incubation, the cells
were resuspended in HBSS buffer and analyzed by using a
flow cytometry (BD Biosciences San Jose, CA, USA). The
fluorescence was excited at 488 nm and examined at 525nm.
To analyze the [Ca2+]i level in rat left ventricular tissues,
the number of free calcium-cresolphthalein complexone
formed within the tissues were detected by using the calcium
detection assay kit (ab102505, Abcam, Cambridge, MA,
USA), according to the manufacturer’s instructions. Briefly,
left ventricular samples were harvested at the end of reperfu-
sion. After treatment with calcium detection solution 1ml for
3min, the samples were centrifuged at 12000 g at 4°C for
3min, and the supernatant was collected. Supernatant 50μl,
chromogenic reagent 90μl, and buffer solution 60μl were
cultured in 96-well plates at room temperature for 10min.
The absorbance values were measured at 575 nm on the
microplate reader.
2.14. Enzyme-Linked Immunosorbent Assay. Serum samples
were collected and frozen at -80°C before assays. A commer-
cial ELISA kit (Life diagnostics, Lincoln, USA) was used as
previously described [30]. The absorbance values were mea-
sured at 450nm on a microplate reader. The cTnI concentra-
tions were determined by using a standard curve.
2.15. Statistical Analysis. All data were expressed as mean ±
standard error of themean ðSEMÞ and analyzed by using
the GraphPad Prism software (version 7.0, GraphPad,
San Diego, CA, USA). Data were compared by using
one-way or two-way analysis of variance followed by Bon-
ferroni or Dunnet posttest, as appropriate. A two-tailed
value of P < 0:05 was considered statistically significant.
3. Results
3.1. Upregulated Hsp70 Protein Expression and p38
MAPK Phosphorylation during OGD/R-Induced Injury in
Cardiomyocytes. In neonatal rat cardiomyocytes, OGD/R treat-
ment significantly resulted in lower cell viability (Figure 2(a))
and resulted in higher LDH release (Figure 2(b)) and level
of [Ca2+]i (Figure 2(c)). Of the three OGD/R groups,
OGR/R-2h led to the lowest cell viability and highest LDH
release and [Ca2+]i level. Besides, cells subjected to OGD/R
showed significantly increased protein expression of Hsp70
and p-p38 MAPK, with the highest protein expression in
the OGD/R-2h group (Figures 2(d)–2(f)). Based on these
findings, OGD for 6 h followed by reoxygenation for 2 h
was selected for the subsequent cell experiments.
3.2. Increased Protein Expression of Hsp70 and
Phosphorylated p38 MAPK during I/R-Induced Myocardial
Injury in Rats.As shown in Table 1, oxygenation and homeo-
stasis were well maintained in all groups during the study
period. Myocardial I/R resulted in significant myocardial
infarct size (IA/AAR) at 30min, 2 h, and 24h of reperfusion,
although AAR/left ventricle (LV) were comparable among
the I/R groups (Figures 3(a)–3(b)). Compared to the sham
rats, the myocardial I/R rats showed significantly higher
levels of serum cTnI (Figure 3(c)) and [Ca2+]i in the myocar-
dium (Figure 3(d)). During the reperfusion process, serum
cTnI level peaked at 24 h of reperfusion while myocardial
[Ca2+]i level decreased over time. Moreover, the protein
expression of Hsp70 and p-p38 MAPK were significantly
increased at 30min and 2h of reperfusion and returned to
normal value at 24 h, with the most obvious level at 30min
(Figures 3(e)–3(g)). Based on these findings, ischemia for
30min followed by reperfusion for 30min was selected for
the following experiments in rats.
3.3. Inhibition of p38 MAPK Alleviated OGD/R-Induced Cell
Injury, [Ca2+]i Overload, and Apoptosis in Cardiomyocytes.
Pretreatment with SB203580, a p38 MAPK inhibitor, signifi-
cantly increased cell viability (Figure 4(a)) and reduced LDH
release (Figure 4(b)) and [Ca2+]i overload (Figure 4(c)) dur-
ing OGD/R-induced injury in neonatal rat cardiomyocytes.
Also, OGD/R led to activation of IL-1β (Figure 4(d)) and
IL-6 (Figure 4(e)) as well as significant cell apoptosis
(Figures 4(f)–4(g)), which was partly blocked by SB203580.
Cells subjected to OGD/R exhibited increased protein
expression of Hsp70, p-p38 MAPK, and cleaved-caspase3
and decreased expression of SERCA2 and p-STAT3, while
pretreatment with SB203580 reversed the changes in these
proteins except for Hsp70 (Figure 5).
3.4. Inhibition of p38 MAPK Attenuated I/R-Induced
Myocardial Injury, [Ca2+]i Overload, and Apoptosis in Rats.
Inhibition of p38 MAPK by SB203580 pretreatment signifi-
cantly improved myocardial infarct size (Figures 6(a)–6(b)),
reduced serum cTnI level (Figure 6(c)), and alleviated
[Ca2+]i overload (Figure 6(d)) during I/R-induced myocar-
dial injury in rats. Myocardial I/R also significantly ele-
vated the mRNA expression of IL-1β (Figure 6(e)) and
IL-6 (Figure 6(f)) as well as myocardial apoptosis rate
(Figures 6(g)–6(h)), which was effectively inhibited by
SB203580. Moreover, the protein expression of Hsp70, p-
p38 MAPK, p-STAT3, and cleaved-caspase3 were upregu-
lated and SERCA2 was downregulated during myocardial
I/R, while SB203580 pretreatment partly reversed most of
these changes (Figure 7). In line with the results in cells,
SB203580 did not affect the expression of Hsp70.
3.5. Knockdown of Hsp70 Aggravated OGD/R-Induced Injury
through p38 MAPK Signaling. Transfection with shRNA-
Hsp70 exacerbated OGD/R-induced changes in cell viability
(Figure 8(a)), LDH release (Figure 8(b)), and [Ca2+]i over-
load (Figure 8(c)) in neonatal rat cardiomyocytes, while inhi-
bition of p38 MAPK by SB203580 significantly attenuated
these effects of Hsp70 knockdown. In addition, the mRNA
levels of IL-1β (Figure 8(d)) and IL-6 (Figure 8(e)) as well
as cell apoptosis rate (Figures 8(f)–8(g)) were further ele-
vated by shRNA-Hsp70 during OGD/R, which was blocked
by p38 MAPK inhibition. Regarding the expression of rele-
vant proteins, shRNA-Hsp70 transfection significantly
reduced the protein expression of Hsp70 during OGD/R. In
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Table 1: Arterial blood analysis.
Sham
(n = 6)
I/R-30min
(n = 6)
I/R-2 h
(n = 6)
I/R-24 h
(n = 6)
pH 7:39 ± 0:03 7:39 ± 0:03 7:40 ± 0:02 7:40 ± 0:03
PaCO2 (mmHg) 37:67 ± 1:80 37:7 ± 2:20 39:33 ± 2:06 40:17 ± 2:27
PaO2 (mmHg) 95:83 ± 2:97 95:33 ± 3:25 96:83 ± 2:79 96:50 ± 2:99
Hct (%) 36:50 ± 2:26 40:33 ± 3:35 41:67 ± 4:96 41:00 ± 3:51
Hb (g/dl) 12:83 ± 1:05 12:75 ± 1:04 13:58 ± 1:65 13:42 ± 1:25
Na+ (mmol/L) 142:00 ± 1:53 143:00 ± 1:91 142:17 ± 2:48 142:83 ± 1:57
K+ (mmol/L) 4:07 ± 0:20 3:93 ± 0:28 4:28 ± 0:23 4:17 ± 0:34
PaCO2: partial pressure of arterial carbon dioxide; PO2: partial pressure of arterial oxygen; Hct: hematocrit; Hb: hemoglobin; Na
+: sodium; K+: potassium.
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Figure 2: OGD/R-induced cell injury and increased protein expression of Hsp70 and phosphorylated p38 MAPK. (a) Decreased cell viability
following OGD/R (n = 8). (b) Increased LDH release following OGD/R (n = 8). (c) Elevated [Ca2+]i level following OGD/R (n = 5). (d)
Representative western blot bands. (e) Upregulated Hsp70 protein expression following OGD/R (n = 5). (f) Upregulated p-p38 MAPK
protein expression following OGD/R (n = 5). Data are shown as means ± SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the control group; #P < 0:05,
##P < 0:01 vs. the OGD/R-2 h group; &P < 0:05 vs. the control group at 0 h. OGD/R: oxygen-glucose deprivation/reoxygenation.
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addition, knockdown of Hsp70 further increased the protein
expression of p-p38 MAPK and cleaved-caspase3 and
decreased the expression of SERCA2 and p-STAT3 during
OGD/R, while pretreatment with SB203580 reversed these
changes induced by shRNA-Hsp70 (Figure 9).
3.6. Inhibition of Hsp70 Exacerbated Rat Myocardial I/R-
Induced Injury through p38 MAPK Signaling. Inhibition of
Hsp70 by quercetin, an Hsp70 inhibitor, significantly
increased myocardial infarct size (Figures 10(a) and 10(b)),
serum cTnI (Figure 10(c)), and myocardial [Ca2+]i level
(Figure 10(d)) during I/R-induced myocardial injury in rats.
Hsp70 inhibition further activated the expression of IL-1β
(Figure 10(e)) and IL-6 (Figure 10(f)) and increased cell apo-
ptosis (Figures 10(g) and 10(h)). In terms of the protein
expression, Hsp70 inhibition led to upregulation of p-p38
MAPK, p-STAT3, and cleaved-caspase3 and downregulation
of SERCA2 during myocardial I/R injury (Figure 11). The
above-mentioned effects elicited by quercetin were abolished
by inhibiting p38 MAPK with SB203580.
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Figure 3: I/R-induced rat myocardial injury and upregulation of Hsp70 protein and p38 MAPK phosphorylation. (a) Representative Evans
blue/TTC staining images. (b) Elevated myocardial infarct size following myocardial I/R. (c) Increased serum cTnI following myocardial I/R.
(d) Increased [Ca2+]i level following myocardial I/R. (e) Representative western blot bands. (f) Upregulated Hsp70 protein expression
following myocardial I/R. (g) Upregulated p-p38 MAPK protein expression following myocardial I/R. n = 5. Data are shown as means ±
SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the sham group; #P < 0:05, ##P < 0:01 vs. the I/R-30min group. I/R: ischemia/reperfusion; AAR: area at risk;
LV: left ventricle; IA: infarct area.
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4. Discussion
The present study demonstrated that inhibition of Hsp70
exacerbated inflammation, [Ca2+]i overload, and apoptosis
and modulated the expression of p-p38 MAPK, SERCA2,
p-STAT3, and cleaved-caspase3 during OGD/R-induced cell
injury and I/R-induced myocardial injury, based on the
in vitro and in vivo experiments. Moreover, inhibition of
p38 MAPK phosphorylation significantly attenuated the
above-mentioned harmful effects induced by Hsp70 inhibi-
tion and attenuated cell death or myocardial injury. These
results reveal that cardioprotection offered by Hsp70 was
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Figure 4: p38 MAPK inhibition alleviated OGD/R-induced injury, [Ca2+]i overload, and apoptosis in cardiomyocytes. (a) SB203580, a p38
MAPK inhibitor, increased cell viability during OGD/R (n = 8). (b) SB203580 reduced OGD/R-induced LDH release (n = 8). (c) SB203580
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(f) Representative TUNEL staining images. Scale bar = 50μm. (g) SB203580 inhibited OGD/R-induced cell apoptosis (n = 5). Data are
shown as means ± SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the control group; #P < 0:05, ##P < 0:01 vs. the OGD/R group. OGD/R: oxygen-glucose
deprivation/reoxygenation.
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mediated, at least in part, through regulating the p38 MAPK
signaling (Figure 12).
Ca2+ plays a critical role in the excitation-contraction
coupling in cardiac muscle, and Ca2+ homeostasis is essential
for normal heart function. Previous studies have indicated
the effects of Hsp70 on Ca2+ homeostasis during cardiac
I/R injury. Specifically, blockade of Hsp70 synthesis aggra-
vated Ca2+ disorder in rat ventricular myocytes subjected to
simulated ischemia [31], while activation of Hsp70 by pre-
conditioning improved the ischemia-impaired Ca2+ homeo-
stasis [32]. In addition, p38 MAPK pathway is also involved
in the Ca2+ regulation. In isolated cardiomyocytes and per-
fused rat hearts, activation of p38 MAPK signaling induced
[Ca2+]i overload during the I/R process, while inhibiting
p38 MAPK by SB203580 attenuated the I/R-induced injury
by enhancing SERCA2α activity, reducing [Ca2+]i overload,
and suppressing apoptosis [24]. As a calcium pump, SER-
CA2α plays a crucial role in the regulation of Ca2+ homeo-
stasis by reuptake of cytosolic Ca2+ into the sarcoplasmic
reticulum [33]. During myocardial I/R injury, decreased
SERCA activity leads to contractile dysfunction and triggers
calcium-dependent injury [34, 35]. In our study, myocar-
dial I/R induced [Ca2+]i overload, upregulation of p-p38
MAPK, and downregulation of SERCA2, which was effec-
tively blocked by inhibition of p38 MAPK with SB203580
pretreatment. Of note, as shown in Figure 8, SB203580
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Figure 5: p38 MAPK inhibition reversed OGD/R-induced protein expression of p-p38 MAPK, SERCA2, p-STAT3, and cleaved
caspase3, but not Hsp70, in cardiomyocytes. (a) Representative western blot bands. (b) Hsp70 protein expression. (c) p-p38 MAPK
protein expression. (d) SERCA2 protein expression. (e) p-STAT3 protein expression. (f) Cleaved caspase3 protein expression. n = 5.
Data are shown as means ± SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the control group; #P < 0:05, ##P < 0:01 vs. the OGD/R group. OGD/R:
oxygen-glucose deprivation/reoxygenation.
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administration led to lower [Ca2+]i level and expression of
IL-1β and IL-6 mRNA compared to the NC +OGD/R
group, and the values of IL-1β and IL-6 were close to the
NC (negative control transfection) group. In addition,
SB203580 led to reduced apoptosis rate of ~20% compared
to ~30% in the NC +OGD/R group. However, these differ-
ences were not statistically significant. As the OGD/R or
myocardial I/R is a complex pathophysiological process
with a number of underlying mechanisms, targeting only
one mechanism is not likely to produce a strong enough
protective effect to bring the cells back to the control level.
Based on our findings, p38 MAPK is a key factor via which
Hsp70 protects against OGD/R-induced cell injury or I/R-
induced myocardial injury.
The organ-protective role of Hsp70 has been indicated in
several animal models. In focal cerebral ischemia in mice,
knockout of Hsp70 significantly increased the infarct vol-
ume, suggesting the cerebral protective effect of Hsp70 [36].
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Figure 6: p38 MAPK inhibition attenuated I/R-induced myocardial injury, [Ca2+]i overload, and apoptosis in rat hearts. (a) Representative
Evans blue/TTC staining images. (b) SB203580 reduced I/R-induced myocardial infarct size. (c) SB203580 reduced serum cTnI level during
myocardial I/R. (d) SB203580 reduced [Ca2+]i level during myocardial I/R. (e and f) SB203580 inhibited myocardial I/R-induced IL-1β and
IL-6 mRNA expression. (g) Representative TUNEL staining images. Scale bar = 50 μm. (h) SB203580 inhibited I/R-induced myocardial
apoptosis. n = 5. Data are shown as means ± SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the sham group; ##P < 0:01 vs. the I/R group. I/R:
ischemia/reperfusion; AAR: area at risk; LV: left ventricle; IA: infarct area.
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In primary rat hypothalamic cells, inhibition of HSP72, a
member of the Hsp70 family, aggravated heat-induced cell
death, while activation of HSP72 by mild heat precondition-
ing significantly attenuated cell injury [37]. In addition,
Hsp70 takes part in the modulation of immune and inflam-
matory responses during tissue injury. A previous study
showed that macrophages with accumulated Hsp70 had
decreased secretion of inflammatory cytokines including
tumor necrosis factor-α and IL-6 [38]. In our study, inhibi-
tion of Hsp70 further enhanced the expression level of IL-
1β and IL-6 during myocardial I/R injury. However, HSPs
can also be released into the extracellular environment to
produce a diverse interaction with cells [39]. Extracellular
Hsp70 induced cardiomyocyte inflammation and decreased
contractility via toll-like receptors and nuclear factor-κB in
primary cardiomyocytes [40]. Moreover, long-term overex-
pression of Hsp70 failed to prevent cardiac dysfunction and
adverse remodeling following chronic heart failure and atrial
fibrillation [41]. In this context, the role of Hsp70 in cardiac
I/R injury still remains unclear. In myocardial I/R mice,
Dillmann and colleagues showed that knockout of Hsp70
genes resulted in the development of cardiac hypertrophy
after myocardial I/R injury, which may be related to several
signaling pathways including Jun N-terminal kinase (JNK),
p38 MAPK, Raf-1, and extracellular signal-regulated kinase
(ERK) [42]. However, it is still unclear whether Hsp70 mod-
ulates p38MAPK signaling and its effects on [Ca2+]i overload
and cell apoptosis during myocardial I/R injury. Our study
confirmed that the upregulation of Hsp70 played a protective
role against OGD/R-induced cell injury in neonatal rat cardi-
omyocytes and I/R-induced myocardial injury in rats
through the inhibition of p38 MAPK signaling.
STAT3 is a transcription factor involved in myocardial
I/R injury [43, 44]. Studies showed that the activation of
STAT3 reduced myocardial infarct size through suppressing
the expression of proapoptotic protein caspase3 [45, 46]. A
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Figure 7: p38 MAPK inhibition reversed myocardial I/R-induced protein expression of p-p38 MAPK, SERCA2, p-STAT3, and cleaved
caspase3, but not Hsp70, in rat hearts. (a) Representative western blot bands. (b) Hsp70 protein expression. (c) p-p38 MAPK protein
expression. (d) SERCA2 protein expression. (e) p-STAT3 protein expression. (f) Cleaved caspase3 protein expression. n = 5. Data are
shown as means ± SEM. ∗∗P < 0:01 vs. the sham group; #P < 0:05, ##P < 0:01 vs. the I/R group. I/R: ischemia/reperfusion.
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Figure 8: Aggravation of OGD/R-induced cell injury by Hsp70 knockdown was blocked by p38 MAPK inhibition. (a) shRNA-Hsp70 further
reduced cell viability during OGD/R, which was abolished by SB203580 (n = 8). (b) Increase in LDH release by shRNA-Hsp70 was blocked by
SB203580 (n = 8). (c) shRNA-Hsp70 further increased [Ca2+]i level during OGD/R, which was inhibited by SB203580 (n = 5). (d and e)
shRNA-Hsp70 further activated IL-1β and IL-6 mRNA expression, which was blocked by SB203580 (n = 5). (f) Representative TUNEL
staining images. Scale bar = 50μm. (g) shRNA-Hsp70 further increased cell apoptosis during OGD/R, which was reversed by SB203580
(n = 5). Data are shown as means ± SEM. ∗P < 0:05, ∗∗P < 0:01 vs. the NC group; #P < 0:05, ##P < 0:01 vs. the NC +OGD/R group;
&&P < 0:01 vs. the sh −Hsp70 + OGD/R group. NC: negative control transfection; OGD/R: oxygen-glucose deprivation/reoxygenation.
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recent study also indicated that promoting STAT3 phos-
phorylation alleviated I/R injury in mouse hearts [47]. These
results were consistent with the findings in our in vitro
experiment. We found that p38 MAPK inhibition attenu-
ated OGD/R-induced injury in neonatal rat cardiomyocytes
through increasing STAT3 phosphorylation and inhibiting
apoptosis and inflammation. However, there is a discrepancy
of STAT3 expression between the cell and rat experiments in
our study. In rats, we found that p38 MAPK inhibition pro-
tected the heart against I/R injury, which was associated with
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Figure 9: Changes in protein expression of p-p38 MAPK, p-STAT3, SERCA2, and cleaved caspase3 caused by shRNA-Hsp70 in cells were
blocked by p38 MAPK inhibition. (a) Representative western blot bands. (b) Hsp70 protein expression. (c) p-p38 MAPK protein expression.
(d) p-STAT3 protein expression. (e) SERCA2 protein expression. (f) Cleaved caspase3 protein expression. n = 5. Data are shown as means
± SEM. ∗∗P < 0:01 vs. the NC group; #P < 0:05, ##P < 0:01 vs. the NC+OGD/R group; &P < 0:05, &&P < 0:01 vs. the sh −Hsp70 + OGD/R
group. NC: negative control transfection; OGD/R: oxygen-glucose deprivation/reoxygenation.
13Oxidative Medicine and Cellular Longevity
decreased STAT3 phosphorylation. Similarly, Szczepanek
et al. [48] showed that transcriptionally inactive STAT3 sig-
nificantly alleviated myocardial I/R injury and improved sur-
vival rate in mice. In other organs, inhibition of STAT3
signaling reduced renal or intestinal I/R injury through the
suppression of caspase3-dependent apoptosis [49, 50].
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Figure 10: Exacerbation of I/R-induced myocardial injury by Hsp70 inhibition was abolished by p38 MAPK inhibition. (a) Representative
Evans blue/TTC staining images. (b) Quercetin, an Hsp70 inhibitor, further increased myocardial infarct size, which was blocked by
SB203580. (c) SB203580 blocked quercetin-induced increase in serum cTnI. (d) SB203580 inhibited quercetin-induced increase in [Ca2+]i
level. (e and f) SB203580 suppressed quercetin-induced IL-1β and IL-6 mRNA activation. (g) Representative TUNEL staining images.
Scale bar = 50μm. (h) SB203580 reversed quercetin-induced elevation in cell apoptosis. n = 5. Data are shown as means ± SEM. ∗P < 0:05,
∗∗P < 0:01 vs. the sham group; ##P < 0:01 vs. the I/R group; &P < 0:05, &&P < 0:01 vs. the Que + I/R group. I/R: ischemia/reperfusion;
AAR: area at risk; LV: left ventricle; IA: infarct area.
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Regarding the effects of STAT3 on inflammation, one study
showed that the activation of phosphorylated STAT3 during
myocardial I/R reduced the levels of inflammatory factors
such as IL-6 and TNF-α, but other studies found that sup-
pressing JAK2/STAT3 signaling resulted in lower levels of
IL-6, IL-8, and TNF-α [51, 52]. Therefore, STAT3 activation
and phosphorylation could be beneficial or detrimental
based on different conditions. In this context, more studies
are still needed to verify the role of STAT3 in I/R-induced
cardiac injury.
This study has several limitations. First, this study inves-
tigated OGD/R-induced cell injury and I/R-induced myocar-
dial injury in an early stage, i.e., reoxygenation for 2 h and
reperfusion for 30min. The myocardial infarct size was
nearly doubled at 24h compared to 2 h, which was in line
with the changes in serum cTnI. The protein expression of
Hsp70 and p-p38 MAPK peaked at 30min, causing signifi-
cant calcium overload in the early period of reperfusion.
These results indicate a progressive cardiac injury during
reperfusion, although several indices gradually decreased. It
is also possible that other mechanisms were involved in the
late period of reperfusion. Second, as this study aimed to
explore whether targeting Hsp70 could affect myocardial
I/R injury through regulating p38 MAPK signaling, the inter-
action between p38 MAPK and STAT3 was not evaluated.
Third, the current results suggest that the upregulation of
Hsp70 was protective against myocardial I/R injury. How-
ever, it is still hard to extrapolate that overexpression of
Hsp70 could exert further cardioprotection. Last, whether
the regulation of p38 MAPK signaling by Hsp70 underlies
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Figure 11: Changes in protein expression of p-p38 MAPK, p-STAT3, SERCA2, and cleaved caspase3 caused by quercetin in myocardial
I/R rats were blocked by p38 MAPK inhibition. (a) Representative western blot bands. (b) p-p38 MAPK protein expression. (c) p-STAT3
protein expression. (d) SERCA2 protein expression. (e) cleaved caspase3 protein expression. n = 5. Data are shown as means ± SEM.
∗P < 0:05, ∗∗P < 0:01 vs. the sham group; #P < 0:05 vs. the I/R group; &P < 0:05, &&P < 0:01 vs. the Que + I/R group. I/R:
ischemia/reperfusion.
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ischemic preconditioning during myocardial I/R process also
needs to be investigated.
In conclusion, this study revealed that inhibition of Hsp70
aggravated myocardial I/R-induced cardiomyocyte inflamma-
tion, [Ca2+]i overload, and caspase3-dependent apoptosis
through regulating the p38 MAPK signaling pathway. These
results address the important role of Hsp70 and p38 MAPK
during I/R-induced myocardial injury, which may provide
novel insight into the therapeutic targets for cardioprotection.
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